| ID | 56185 |
| JaLCDOI | |
| FullText URL | |
| Author |
Koga, Yuhki
Department of Pediatrics, Graduate School of Medical Sciences Kyushu University
Baba, Shingo
Department of Clinical Radiology, Kyushu University Hospital
Fukano, Reiji
Department of Pediatrics, Yamaguchi University Graduate School of Medicine
Nakamura, Katsumasa
Department of Radiation Oncology, Hamamatsu University School of Medicine
Soejima, Toshinori
Department of Radiation Oncology, Hyogo Cancer Center
Maeda, Naoko
Department of Pediatrics, Nagoya Medical Center
Sunami, Shosuke
Department of Pediatrics, Japanese Red Cross Narita Hospital
Ueyama, Junichi
iDepartment of Pediatrics, Tottori University Hospital
Mitsui, Tetsuo
Department of Pediatrics, Yamagata University Hospital,
Mori, Takeshi
Department of Pediatrics, Kobe University
Osumi, Tomoo
Children’s Cancer Center, National Center for Child Health and Development,
Sekimizu, Masahiro
Department of Pediatrics, Nagoya Medical Center
Ohki, Kentaro
Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development
Tanaka, Fumiko
Department of Pediatrics, Saiseikai Yokohamashi Nanbu Hospital
Kamei, Michi
Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences
Fujita, Naoto
Department of Pediatrics, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital
Mori, Tetsuya
Department of Pediatrics, St. Marianna University School of Medicine Hospital
Saito, Akiko M.
Clinical Research Center, Nagoya Medical Center
Kada, Akiko
Clinical Research Center, Nagoya Medical Center
Kobayashi, Ryoji
Department of Pediatrics and Adolescence, Sapporo Hokuyu Hospital
|
| Abstract | This trial enrolls patients with untreated Hodgkin’s lymphoma aged<20 years at diagnosis and examines the effects of omitting radiation therapy if the FDG-positron emission tomography (PET) findings after two completed cycles of combination chemotherapy are negative. It thereby aims to determine whether patients who truly require radiation therapy can be identified by FDG-PET. If so, this modality could be used to omit radiation therapy for all other patients, decreasing the risk of serious long-term complications without affecting survival rates. The outcomes of patients for whom FDG-PET is used to assess early treatment response will also be determined.
|
| Keywords | Hodgkin’s lymphoma
pediatric
fludeoxyglucose positron emission tomography
|
| Amo Type | Clinical Study Protocol
|
| Publication Title |
Acta Medica Okayama
|
| Published Date | 2018-08
|
| Volume | volume72
|
| Issue | issue4
|
| Publisher | Okayama University Medical School
|
| Start Page | 437
|
| End Page | 440
|
| ISSN | 0386-300X
|
| NCID | AA00508441
|
| Content Type |
Journal Article
|
| language |
English
|
| Copyright Holders | CopyrightⒸ 2018 by Okayama University Medical School
|
| File Version | publisher
|
| Refereed |
True
|
| PubMed ID |
